Health Care·Health Care Services·$7.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.05 | N/A | +68.75% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.05 | N/A | +68.75% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS surprise but did not provide specific revenue figures. They emphasized their commitment to growth and customer acquisition.
We are pleased with our EPS performance this quarter.
Our focus remains on expanding our customer base and product offerings.
HIMS & HERS reported a smaller-than-expected loss per share, which was a positive surprise for investors. However, the stock fell by 3.44% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious as the company continues to navigate its growth strategy without clear revenue expectations.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BIONTECH SE ADR
Aug 9, 2021